Peter N. Laivins

2014

In 2014, Peter N. Laivins earned a total compensation of $897.6K as Former Head of Development at Merrimack Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$95,575
Option Awards$519,755
Salary$273,201
Other$9,050
Total$897,581

Laivins received $519.8K in option awards, accounting for 58% of the total pay in 2014.

Laivins also received $95.6K in non-equity incentive plan, $273.2K in salary and $9.1K in other compensation.

Rankings

In 2014, Peter N. Laivins' compensation ranked 8,075th out of 13,032 executives tracked by ExecPay. In other words, Laivins earned more than 38.0% of executives.

ClassificationRankingPercentile
All
8,075
out of 13,032
38th
Division
Manufacturing
2,990
out of 4,966
40th
Major group
Chemicals And Allied Products
1,015
out of 1,686
40th
Industry group
Drugs
798
out of 1,365
42nd
Industry
Pharmaceutical Preparations
621
out of 1,043
41st
Source: SEC filing on June 26, 2017.

Laivins' colleagues

We found five more compensation records of executives who worked with Peter N. Laivins at Merrimack Pharmaceuticals in 2014.

2014

Robert Mulroy

Merrimack Pharmaceuticals

Chief Executive Officer

2014

Ulrik Nielsen

Merrimack Pharmaceuticals

Chief Scientific Officer

2014

William McClements

Merrimack Pharmaceuticals

Former Head of Corporate Operations

2014

Edward Stewart

Merrimack Pharmaceuticals

Former Head of Commercial

2014

William Sullivan

Merrimack Pharmaceuticals

Chief Financial Officer

In-depth

You may also like